Monopar Therapeutics MNPR
NASDAQ MNPR
$77.97 -1.70 (-2.13%)
At close: Oct 1, 2026 · 4:00 PM EDT

Monopar Therapeutics (MNPR) Invested Capital (2019 - 2020)

Updated

Monopar Therapeutics (MNPR) posted Invested Capital of $17.61 million for Q3 2020, up 43.5% from the prior quarter.

Analysis

Monopar Therapeutics (MNPR) Invested Capital (2019 - 2020) Analysis & Trends

For FY2019, Monopar Therapeutics' Invested Capital came in at $12.63 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 134.01 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 64.89 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 95.89 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 79.44 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 50.26 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 68.99 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 38.08 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 148.69 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Monopar Therapeutics 680.58 Mn 398.81 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 17.61 Mn
Jun 30, 2020 12.28 Mn
Dec 31, 2019 12.63 Mn
API Access

Monopar Therapeutics Invested Capital API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=invested-capital&ticker=MNPR&period=max&api_key=YOUR_API_KEY